{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:45:39Z","timestamp":1761126339976},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":655,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2000,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:bold>\n            <jats:italic>Background<\/jats:italic>\n          <\/jats:bold>: Although dysphagia resulting from oesophageal strictures induced by endoscopic injection sclerotherapy (EIS) is not a fatal complication, it is often quite distressing for the patients. The aim of the current study was to clarify the relationship between dysphagia resulting from oesophageal stricture following prophylactic EIS and the volume of sclerosant consumed in the EIS series.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>: Fifty\u2010two patients with oesophageal varices, who had been treated by prophylactic EIS, were selected as the subjects.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>: Seventeen (32.7%) patients developed dysphagia following prophylactic EIS, and five patients with a severe stricture required bougie dilatation to take meals. The volume of sclerosant used in the initial session of EIS for patients with subsequent dysphagia (24.9 \u00b1 4.0 mL) was significantly larger than that for patients without dysphagia (18.4 \u00b1 5.1 mL; <jats:italic>P<\/jats:italic> &lt; 0.001). The mean volume of sclerosant consumed per session during the EIS series for patients with dysphagia (16.5 \u00b1 3.0 mL) was also significantly larger than that for patients without dysphagia (13.1 \u00b1 3.8 mL; <jats:italic>P<\/jats:italic> &lt; 0.01).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>: The injection of a superfluous amount of sclerosant in prophylactic EIS brings about distressing dysphagia with oesophageal stricture in the patients with oesophageal varices who had no such complaint or symptoms before the therapy.<\/jats:p><jats:p>\u00a9 2000 Blackwell Science Asia Pty Ltd<\/jats:p>","DOI":"10.1046\/j.1440-1746.2000.02128.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:14:01Z","timestamp":1047446041000},"page":"320-323","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dysphagia after prophylactic endoscopic injection sclerotherapy for oesophageal varices: Not fatal but a distressing complication"],"prefix":"10.1111","volume":"15","author":[{"given":"Tadahiro","family":"Nozoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Sugimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1996.tb01836.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150114"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150113"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060631"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91056-1"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"e_1_2_5_8_2","volume-title":"The General Rules for Study of Portal Hypertension","author":"Japanese Research Society for Portal Hypertension","year":"1996"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(81)73224-3"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80866-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000128777"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(83)90027-6"},{"key":"e_1_2_5_13_2","first-page":"162","article-title":"Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.","author":"Hashizume M","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_5_14_2","first-page":"269","article-title":"Ethanolamine oleate and acute renal failure.","volume":"82","author":"Maling TJB","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018858525312"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250113"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.706"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280215"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-1-199307010-00001"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.5.473"},{"key":"e_1_2_5_21_2","first-page":"767","article-title":"Endoscopic sclerotherapy: An analysis of variants.","volume":"8","author":"Conn HO.","year":"1983","journal-title":"Hepatology"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(81)73148-1"},{"key":"e_1_2_5_23_2","first-page":"567","article-title":"Injection sclerotherapy\u2010induced esophageal strictures. Risk factor and prognosis.","volume":"57","author":"Guynn TP","year":"1991","journal-title":"Am. Surg."},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90107-A"},{"key":"e_1_2_5_25_2","first-page":"381","article-title":"The surgeon\u2019s role in the management of portal hypertension.","volume":"209","author":"Terblanche J.","year":"1989","journal-title":"Ann. Surg."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1746.2000.02128.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1746.2000.02128.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1440-1746.2000.02128.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1746.2000.02128.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:22:45Z","timestamp":1694413365000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1746.2000.02128.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,10]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3,10]]}},"alternative-id":["10.1046\/j.1440-1746.2000.02128.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1746.2000.02128.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,10]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}